Wealth Shield Partners, LLC Abb Vie Inc. Transaction History

Wealth Shield Partners, LLC

$721 Million
Q3 2024

A detailed history of Wealth Shield Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Shield Partners, LLC holds 4,793 shares of ABBV stock, worth $862,740. This represents 0.13% of its overall portfolio holdings.

Number of Shares

4,793

Previous 4,630 3.52%

Holding current value

$862,740

Previous $794,000 19.14%

% of portfolio

0.13%

Previous 0.12%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$163.84 - $199.33 $26,705 - $32,490	163 Added 3.52%	4,793 $946,000
Q2 2024 Jul 26, 2024	BUY	$154.79 - $180.76 $32,196 - $37,598	208 Added 4.7%	4,630 $794,000
Q1 2024 Apr 29, 2024	SELL	$159.82 - $182.1 $39,955 - $45,525	-250 Reduced 5.35%	4,422 $805,000
Q4 2023 Jan 23, 2024	SELL	$137.6 - $154.97 $24,217 - $27,274	-176 Reduced 3.63%	4,672 $724,000
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $37,538 - $43,456	281 Added 6.15%	4,848 $722,000
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $61,484 - $76,513	-464 Reduced 9.22%	4,567 $615,000
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $61,459 - $70,779	-425 Reduced 7.79%	5,031 $801,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $17,427 - $20,899	-126 Reduced 2.26%	5,456 $882,000
Q3 2022 Nov 04, 2022	BUY	$134.21 - $153.93 $6,039 - $6,926	45 Added 0.81%	5,582 $749,000
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $22,707 - $28,868	165 Added 3.07%	5,537 $848,000
Q1 2022 May 09, 2022	SELL	$131.98 - $163.75 $138,183 - $171,446	-1,047 Reduced 16.31%	5,372 $871,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $363,650 - $460,123	3,385 Added 111.57%	6,419 $869,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $209,714 - $238,057	-1,971 Reduced 39.38%	3,034 $327,000
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $47,134 - $52,510	448 Added 9.83%	5,005 $564,000
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $190,891 - $210,148	-1,866 Reduced 29.05%	4,557 $493,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $46,201 - $62,376	-574 Reduced 8.2%	6,423 $688,000
Q3 2020 Oct 30, 2020	BUY	$85.91 - $100.83 $177,747 - $208,617	2,069 Added 41.98%	6,997 $613,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $108,294 - $144,913	-1,476 Reduced 23.05%	4,928 $484,000
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $413,058 - $626,247	6,404 New	6,404 $488,000
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $245,586 - $313,917	-3,738 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $46,515 - $54,746	603 Added 19.23%	3,738 $301,000
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $35,888 - $44,260	-461 Reduced 12.82%	3,135 $289,000
Q3 2018 Nov 05, 2018	SELL	$88.91 - $98.84 $8,535 - $9,488	-96 Reduced 2.6%	3,596 $340,000
Q2 2018 Aug 02, 2018	SELL	$89.78 - $106.23 $7,631 - $9,029	-85 Reduced 2.25%	3,692 $342,000
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $33,215 - $44,478	-361 Reduced 8.72%	3,777 $357,000
Q4 2017 Apr 18, 2018	BUY	$89.56 - $98.21 $370,599 - $406,392	4,138	4,138 $406,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Shield Partners, LLC with notifications on news.

Account

Wealth Shield Partners, LLC Abb Vie Inc. Transaction History